In Thursday’s Wall Street session, Evolent Health Inc (NYSE:EVH) shares traded at $8.45, down -2.20% from the previous session.
EVH stock price is now -6.51% away from the 50-day moving average and -42.73% away from the 200-day moving average. The market capitalization of the company currently stands at $992.02M.
With the price target of $15, Needham recently initiated with Buy rating for Evolent Health Inc (NYSE: EVH). On December 03, 2024, BTIG Research reiterated its ‘Buy’ rating on the stock by increasing its target price from $36 to quote $29, while ‘Stephens’ rates the stock as ‘Equal-Weight’
In other news, Holder Diane, Director bought 2,735 shares of the company’s stock on Mar 06 ’25. The stock was bought for $25,518 at an average price of $9.33. Upon completion of the transaction, the Director now directly owns 70,584 shares in the company, valued at $0.6 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 06 ’25, PRESIDENT McCarthy Daniel Joseph bought 11,040 shares of the business’s stock. A total of $99,470 was incurred on buying the stock at an average price of $9.01. This leaves the insider owning 389,004 shares of the company worth $3.29 million. A total of 2.65% of the company’s stock is owned by insiders.
During the past 12 months, Evolent Health Inc has had a low of $7.06 and a high of $33.63. As of last week, the company has a debt-to-equity ratio of 1.14, a current ratio of 0.98, and a quick ratio of 0.98.
The net profit margin was -5.86% and return on equity was -10.99% for EVH. For the current quarter, analysts expect EVH to generate $459.43M in revenue.
